Literature DB >> 20476868

Non-participation in EIRA: a population-based case-control study of rheumatoid arthritis.

C Bengtsson, A Berglund, M-L Serra, L Nise, B Nordmark, L Klareskog, L Alfredsson.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20476868     DOI： 10.3109/03009740903501634

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  18 in total

1.  Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden.

Authors:  Thomas Frisell; Karin Hellgren; Lars Alfredsson; Soumya Raychaudhuri; Lars Klareskog; Johan Askling
Journal:  Ann Rheum Dis       Date:  2014-12-12       Impact factor: 19.103

2.  Shared epitope alleles remain a risk factor for anti-citrullinated proteins antibody (ACPA)--positive rheumatoid arthritis in three Asian ethnic groups.

Authors:  Too Chun-Lai; Leonid Padyukov; Jasbir Singh Dhaliwal; Emeli Lundström; Abqariyah Yahya; Nor Asiah Muhamad; Lars Klareskog; Lars Alfredsson; Per Tobias Larsson; Shahnaz Murad
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

3.  Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate.

Authors:  Reem Altawil; Saedis Saevarsdottir; Sara Wedrén; Lars Alfredsson; Lars Klareskog; Jon Lampa
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-08       Impact factor: 4.794

4.  Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Authors:  Cecilia Orellana; Saedis Saevarsdottir; Lars Klareskog; Elizabeth W Karlson; Lars Alfredsson; Camilla Bengtsson
Journal:  Ann Rheum Dis       Date:  2017-08-17       Impact factor: 19.103

5.  Working in cold environment and risk of developing rheumatoid arthritis: results from the Swedish EIRA case-control study.

Authors:  Pingling Zeng; Camilla Bengtsson; Lars Klareskog; Lars Alfredsson
Journal:  RMD Open       Date:  2017-08-16

6.  Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.

Authors:  Vivek Anand Manivel; Mohammed Mullazehi; Leonid Padyukov; Helga Westerlind; Lars Klareskog; Lars Alfredsson; Saedis Saevarsdottir; Johan Rönnelid
Journal:  Ann Rheum Dis       Date:  2017-03-23       Impact factor: 19.103

7.  Physical workload is associated with increased risk of rheumatoid arthritis: results from a Swedish population-based case-control study.

Authors:  Pingling Zeng; Lars Klareskog; Lars Alfredsson; Camilla Bengtsson
Journal:  RMD Open       Date:  2017-03-14

8.  Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register.

Authors:  Xia Jiang; Maria E C Sandberg; Saedis Saevarsdottir; Lars Klareskog; Lars Alfredsson; Camilla Bengtsson
Journal:  Arthritis Res Ther       Date:  2015-11-06       Impact factor: 5.156

9.  Postmenopausal hormone therapy and the risk of rheumatoid arthritis: results from the Swedish EIRA population-based case-control study.

Authors:  Cecilia Orellana; Saedis Saevarsdottir; Lars Klareskog; Elizabeth W Karlson; Lars Alfredsson; Camilla Bengtsson
Journal:  Eur J Epidemiol       Date:  2015-03-12       Impact factor: 8.082

10.  Parity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA material.

Authors:  Mitra Pikwer; Cecilia Orellana; Henrik Källberg; Andreas Pikwer; Carl Turesson; Lars Klareskog; Lars Alfredsson; Saedis Saevarsdottir; Camilla Bengtsson
Journal:  Arthritis Res Ther       Date:  2015-12-12       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.